AgomAb Therapeutics NV
AGMBNasdaqCIK 2020932HealthcareFiscal year ends Dec 31
Reports and events: 13 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1321:18 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-13 | 0001104659-26-115567 |
| 2026-10-0110:42 ET | 6-K | Report of a foreign private issuerPeriod 2026-10-01 | 0001104659-26-112564 |
| 2026-09-1420:14 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-14 | 0001104659-26-107500 |
| 2026-09-1121:02 ET | 6-K | Report of a foreign private issuerPeriod 2026-09-11 | 0001104659-26-107117 |
| 2026-08-1020:17 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-10 | 0001104659-26-093390 |
| 2026-08-0620:06 ET | 6-K | Report of a foreign private issuerPeriod 2026-08-06 | 0001104659-26-091992 |
| 2026-06-2320:13 ET | 6-K | Report of a foreign private issuerPeriod 2026-06-23 | 0001104659-26-076819 |
| 2026-05-2711:12 ET | 6-K | Report of a foreign private issuerPeriod 2026-05-27 | 0001104659-26-066590 |
| 2026-04-2420:22 ET | 6-K | Report of a foreign private issuerPeriod 2026-04-24 | 0001104659-26-048615 |
| 2026-04-2321:17 ET | 20-F | Annual report of a foreign private issuerPeriod 2025-12-31 | 0001104659-26-047872 |
| 2026-03-0521:05 ET | 6-K | Report of a foreign private issuerPeriod 2026-03-05 | 0001104659-26-024095 |
| 2026-02-1712:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-052946 |
| 2026-02-0921:18 ET | 6-K | Report of a foreign private issuerPeriod 2026-02-09 | 0001104659-26-012080 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.